We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

1 hedge funds and large institutions have $2K invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% less capital invested

Capital invested by funds: $3.59K → $2K (-$1.59K)

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$1.56K
2
UBS Group
UBS Group
Switzerland
-$36
Name Holding Trade Value Shares
Change 		Change in
Stake
ADL
1
Asset Dedication LLC
California
$2K – – –
IC
2
Ikarian Capital
Texas
– -$1.56K -301 Closed
UBS Group
3
UBS Group
Switzerland
– -$36 -7 Closed

PHXM Hedge Fund Activity: Q4 2023 in Review

1 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q4 2023, worth a combined $2K — down 44% from $3.59K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PHXM and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Ikarian Capital, exiting entirely with an estimated $1.56K sold.

  • 1 institutional investor held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q4 2023, down from 3 in Q3 2023.
  • Funds reported $2K of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q4 2023, down 44% quarter-over-quarter.
  • 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q4 2023 and 2 closed out, a net change of -2 holders.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q4 2023 was Ikarian Capital, an estimated $1.56K sold.

Based on aggregated 13F filings for Q4 2023.